Consonance Capital Management LP Assembly Biosciences, Inc. Transaction History

Consonance Capital Management LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 17, 2021	SELL	$4.33 - $6.63 $8.53 Million - $13.1 Million	-1,969,875 Closed	0 $0
Q3 2020 Nov 16, 2020	SELL	$15.08 - $27.04 $18.2 Million - $32.6 Million	-1,205,660 Reduced 37.97%	1,969,875 $32.4 Million
Q1 2020 May 15, 2020	BUY	$10.27 - $21.23 $13.3 Million - $27.5 Million	1,297,140 Added 69.06%	3,175,535 $47.1 Million
Q4 2019 Feb 14, 2020	BUY	$8.36 - $23.81 $15.7 Million - $44.7 Million	1,878,395 New	1,878,395 $38.4 Million

16.3K

Ticker ASMB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,436,900
Market Cap $737M
Description
Assembly Biosciences, Inc., a clinical-stage biotechnology company, discovers and develops therapeutic candidates for the treatment of hepatitis B virus (HBV) infection in the United States. The company's lead product candidate is Vebicorvir, which as completed Phase 2 clinical trials to treat patients with chronic HBV infection. It is also deve...

Get notified when there are updates to the investment portfolio of Consonance Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Consonance Capital Management LP with notifications on news.